Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
G. Stabile, G. A. Topouzova & F. De Seta. (2023) The role of microbiota in the management of genitourinary syndrome of menopause. Climacteric 26:4, pages 353-360.
Read now
Read now
C. Castelo-Branco, E. Mension, I. Torras, I. Cebrecos & S. Anglès-Acedo. (2023) Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies. Climacteric 26:4, pages 296-301.
Read now
Read now
Stefano Salvatore, Vittoria Benini, Alessandro Ferdinando Ruffolo, Rebecca S. Degliuomini, Anna Redaelli, Arianna Casiraghi & Massimo Candiani. (2023) Current challenges in the pharmacological management of genitourinary syndrome of menopause. Expert Opinion on Pharmacotherapy 24:1, pages 23-28.
Read now
Read now
Kiandokht Ghamari, Ladan Kashani, Morteza Jafarinia, Borna Tadayon Najafabadi, kamyar Shokraee, Sophia Esalatmanesh & Shahin Akhondzadeh. (2020) Vitamin E and ginseng supplementation to enhance female sexual function: a randomized, double-blind, placebo-controlled, clinical trial. Women & Health 60:10, pages 1164-1173.
Read now
Read now
F. Murina, R. Felice, S. Di Francesco, L. Nelvastellio & I. Cetin. (2020) Ospemifene plus fractional CO2 laser: a powerful strategy to treat postmenopausal vulvar pain. Gynecological Endocrinology 36:5, pages 431-435.
Read now
Read now
David F. Archer, James A. Simon, David J. Portman, Steven R. Goldstein & Irwin Goldstein. (2019) Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause. Expert Review of Endocrinology & Metabolism 14:5, pages 301-314.
Read now
Read now
J. A. Simon, R. Kagan, D. F. Archer, G. D. Constantine, B. Bernick, S. Graham & S. Mirkin. (2019) TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women. Climacteric 22:4, pages 412-418.
Read now
Read now
Iuliia Naumova & Camil Castelo-Branco. (2018) Current treatment options for postmenopausal vaginal atrophy. International Journal of Women's Health 10, pages 387-395.
Read now
Read now
Melanie K. Miller, Joshua R. Smith, Jacqueline J. Norman & Anita H. Clayton. (2018) Expert opinion on existing and developing drugs to treat female sexual dysfunction. Expert Opinion on Emerging Drugs 23:3, pages 223-230.
Read now
Read now
Stefania Alvisi, Maurizio Baldassarre, Valentina Martelli, Giulia Gava, Renato Seracchioli & Maria Cristina Meriggiola. (2017) Effects of ospemifene on vaginal epithelium of post-menopausal women. Gynecological Endocrinology 33:12, pages 946-950.
Read now
Read now
M. L’Hermite. (2017) Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal. Climacteric 20:4, pages 331-338.
Read now
Read now
Santiago Palacios & María Jesús Cancelo. (2016) Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. International Journal of Women's Health 8, pages 617-626.
Read now
Read now
Chiara Bondi, Simone Ferrero, Carolina Scala, Emanuela Tafi, Annalisa Racca, Pier Luigi Venturini & Umberto Leone Roberti Maggiore. (2016) Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1233-1246.
Read now
Read now
R. J. Baber, N. Panay & A. Fenton$suffix/text()$suffix/text(). (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 19:2, pages 109-150.
Read now
Read now
N. Bruyniks, R. E. Nappi, C. Castelo-Branco, T. J. de Villiers & J. Simon. (2016) Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric 19:1, pages 60-65.
Read now
Read now
N. Panay. (2015) Genitourinary syndrome of the menopause – dawn of a new era?. Climacteric 18:sup1, pages 13-17.
Read now
Read now
Articles from other publishers (21)
Rossella E. Nappi, Lara Tiranini, Ellis Martini, David Bosoni, Alessandra Righi & Laura Cucinella. (2022) Medical Treatment of Female Sexual Dysfunction. Urologic Clinics of North America 49:2, pages 299-307.
Crossref
Crossref
Reshma A. Merchant. 2022. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine
1433
1441
.
Elena Colonnello, Erika Limoncin, Giacomo Ciocca, Andrea Sansone, Daniele Mollaioli, Giancarlo Balercia, Hartmut Porst, Hui Zhang, Xi Yu, Yan Zhang & Emmanuele A. Jannini. (2022) The Lost Penis Syndrome: A New Clinical Entity in Sexual Medicine. Sexual Medicine Reviews 10:1, pages 113-129.
Crossref
Crossref
Francesco De Seta, Salvatore Caruso, Giovanni Di Lorenzo, Federico Romano, Mariateresa Mirandola & Rossella E. Nappi. (2021) Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study. Maturitas 147, pages 34-40.
Crossref
Crossref
Shannon L. Wallace, Brad St Martin, Kyueun Lee & Eric R. Sokol. (2020) A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia. American Journal of Obstetrics and Gynecology 223:6, pages 890.e1-890.e12.
Crossref
Crossref
Iyad Baker, David DaHill, Johanna Javier & Jessalyn Wong. (2020) What is the efficacy of nonestrogen therapy for treating AV in postmenopausal women?. Evidence-Based Practice 23:10, pages 23-24.
Crossref
Crossref
Sônia M.R.R. Lima & Juliana V. Honorato. (2019) Critical analysis of methods for assessing genitourinary syndrome of menopause used in clinical trials. Menopause 26:12, pages 1436-1442.
Crossref
Crossref
Brooke M Faught, Graziella Soulban, Jason Yeaw, Christiane Maroun, Katharine Coyle, Samuel Schaffer & Mitch DeKoven. (2019) Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia. Journal of Comparative Effectiveness Research 8:13, pages 1111-1123.
Crossref
Crossref
Irwin Goldstein, James A. Simon, Andrew M. Kaunitz, Corrado Altomare, Yuki Yoshida, Julie Zhu, Sam Schaffer & Graziella Soulban. (2019) Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices. Menopause 26:9, pages 994-1001.
Crossref
Crossref
Salvatore Caruso & Caterina Monaco. (2019) Dyspareunia in Women: Updates in Mechanisms and Current/Novel Therapies. Current Sexual Health Reports 11:1, pages 9-20.
Crossref
Crossref
Jay Jay Thaung Zaw, Peter Ranald Charles Howe & Rachel Heloise Xiwen Wong. (2018) Postmenopausal health interventions: Time to move on from the Women’s Health Initiative?. Ageing Research Reviews 48, pages 79-86.
Crossref
Crossref
Nick Panay. 2018. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
672
688
.
Emmanuele A. Jannini & Rossella E. Nappi. (2018) Couplepause: A New Paradigm in Treating Sexual Dysfunction During Menopause and Andropause. Sexual Medicine Reviews 6:3, pages 384-395.
Crossref
Crossref
Sue W. Goldstein, Ashley G. Winter & Irwin Goldstein. (2018) Improvements to the Vulva, Vestibule, Urethral Meatus, and Vagina in Women Treated With Ospemifene for Moderate to Severe Dyspareunia: A Prospective Vulvoscopic Pilot Study. Sexual Medicine 6:2, pages 154-161.
Crossref
Crossref
Arum LeeTae Hee KimHae Hyeog LeeYeon Suk KimTemuulee EnkhboldBora LeeYoo Jin ParkKisung Song. (2018) Therapeutic Approaches to Atrophic Vaginitis in Postmenopausal Women: A Systematic Review with a Network Meta-analysis of Randomized Controlled Trials. Journal of Menopausal Medicine 24:1, pages 1.
Crossref
Crossref
Nick Panay. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond
261
268
.
Jae Jun ShinSeul Ki KimJung Ryeol LeeChang Suk Suh. (2017) Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy. Journal of Menopausal Medicine 23:2, pages 79.
Crossref
Crossref
Nastassia Sylvestre & Catherine Kim. (2017) Estrogen Therapy in 2017. Current Cardiovascular Risk Reports 11:1.
Crossref
Crossref
Andrew T. Goldstein & Michelle A. King. (2016) Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases. Sexual Medicine 4:3, pages e217-e220.
Crossref
Crossref
Salvatore Stefano, Athanasiou Stavros & Candiani Massimo. (2015) The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Current Opinion in Obstetrics & Gynecology 27:6, pages 504-508.
Crossref
Crossref
Esther Han, Priyanka Gupta & Jason P. Gilleran. (2015) Effect of Hormonal Changes on Voiding in the Elderly Woman. Current Bladder Dysfunction Reports 10:4, pages 362-369.
Crossref
Crossref